Intensive induction chemotherapy vs hypomethylating agent –based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia
Source: Hematological Oncology - Category: Hematology Authors: Matthew J. Lim, Aya Agha, Annie Im, Anastasios Raptis, Jing Z. Hou, Michael Boyiadzis, Alison R. Sehgal, Robert L. Redner, Kathleen Dorritie, Stanley S. Marks, Mounzer E. Agha, Seah H. Lim Tags: LETTER TO THE EDITOR Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Chemotherapy | Hematology | Leukemia